EGFR and lung cancer: Analysis of the cancer genome atlas (TCGA) database, a landmark cancer genomics programme that molecularly characterized over 20 000 primary cancer and matched normal samples spanning 33 cancer types, indicates that DHHC20 is highly expressed in breast and lung cancer cell lines where EGFR signalling is biologically relevant [21].